Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time? [PDF]
Journal of the Endocrine Society, 2021 The WHO Classification of Endocrine Tumours designates pituitary neoplasms as adenomas. A proposed nomenclature change to pituitary neuroendocrine tumors (PitNETs) has been met with concern by some stakeholder groups.
Ken K. Y. Ho +47 more
core +19 more sources
Analyses and treatments of postoperative nasal complications after endonasal transsphenoidal resection of pituitary neoplasms. [PDF]
Medicine (Baltimore), 2017 In this study, we analyze and discuss the treatments of postoperative nasal complications after endonasal transsphenoidal resection of pituitary neoplasms (PNs).
Cheng Y +8 more
europepmc +3 more sources
Pituitary metastases from neuroendocrine neoplasms: case report and narrative review [PDF]
Pituitary, 2021 Purpose Pituitary metastases (PM) are uncommon findings and are mainly derived from breast and lung cancers. No extensive review of PM from neuroendocrine neoplasms (NENs) is on record.
Alberto Ragni +13 more
semanticscholar +7 more sources
Treatment of pituitary neoplasms with temozolomide [PDF]
Cancer, 2010 Temozolomide, an orally administered alkylating agent, is used to treat malignant gliomas. Recent reports also have documented its efficacy in the treatment of pituitary adenomas and carcinomas.
Luis V. Syro +9 more
semanticscholar +5 more sources
Treatment of pituitary neoplasms with temozolomide [PDF]
Cancer, 2011 BACKGROUND: The effectiveness of mammography screening for women ages 40 to 49 years still is questioned, and few studies of the effectiveness of service screening for this age group have been conducted.
Gianluca Marucci
semanticscholar +5 more sources
Analysis of risk factors of pituitary neoplasms invading the sphenoidal sinus. [PDF]
Medicine (Baltimore), 2023 High-resolution computed tomography (HR-CT) can more effectively discern the relationship between pituitary neoplasms (PNs) and neighboring anatomical structures. Moreover, pathological features can facilitate a more accurate determination of the growth pattern of PNs. Consequently, integrating imaging and pathological data might enhance our predictive
Luo B +7 more
europepmc +4 more sources
Three Endocrine Neoplasms: An Unusual Combination of Pheochromocytoma, Pituitary Adenoma, and Papillary Thyroid Carcinoma [PDF]
Thyroid, 2012 Background: Three endocrine neoplasms?bilateral pheochromocytomas, somatotrophic pituitary adenoma inducing acromegaly, and papillary carcinoma of the thyroid?occurred concurrently in a patient. A genetic mutation was hypothesized.
James C. Sisson +2 more
core +4 more sources
Time Dependence of Radiation-induced Hypothalamic–Pituitary Axis Dysfunction in Adults Treated for Non-pituitary, Intracranial Neoplasms [PDF]
Clinical Oncology, 2016 AIMS: Hypothalamic-pituitary axis (HPA) dysfunction is a sequela of cranial radiotherapy. The purpose of this study was to use endocrine data from existing publications to characterise the baseline endocrine status, the effects of radiotherapy on the HPA during the first follow-up year and the time dependence of radiation-induced HPA dysfunction in ...
Nicolette Taku +3 more
semanticscholar +7 more sources
Imaging of pituitary tumors: an update with the 5th WHO Classifications—part 2. Neoplasms other than PitNET and tumor-mimicking lesions [PDF]
Japanese Journal of Radiology, 2023 Many types of tumors can develop in the pituitary gland. In the recently revised 5th editions of the World Health Organization (WHO) classifications (2021 WHO Classification of Central Nervous System Tumors and the 2022 WHO Classification of Endocrine ...
Taro Tsukamoto, Yukio Miki
openalex +2 more sources
Nonneuroendocrine Neoplasms of the Pituitary Region. [PDF]
The Journal of Clinical Endocrinology & Metabolism, 2019 CONTEXT Although most sellar lesions are related to pituitary adenomas, the region gives rise to a variety of neoplasms that can be associated with substantial morbidity and/or mortality.
G. Kaltsas +3 more
semanticscholar +4 more sources